|
Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending November 30, 2020
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jan 27, 2021 06:03PM
|
|
Re: Another article
|
4
|
Resverlogix Corp.
|
Nov 20, 2019 10:00PM
|
|
Re: AHA 2018
|
4
|
Resverlogix Corp.
|
Nov 10, 2018 10:13PM
|
|
Re: European Atherosclerosis Society 2019 meeting May 26-29
|
4
|
Resverlogix Corp.
|
May 24, 2019 11:41AM
|
|
Re: 8 Minutes at AHA
|
4
|
Resverlogix Corp.
|
Oct 24, 2019 09:54PM
|
|
Re: SP Consolidation
|
4
|
Resverlogix Corp.
|
Jun 21, 2019 01:26PM
|
|
Times and place of Resverlogix and Zenith Special Meetings
|
4
|
Resverlogix Corp.
|
Jun 09, 2015 11:49AM
|
|
AGM Notice of Meeting on or about September 30
|
4
|
Resverlogix Corp.
|
Sep 12, 2019 06:52AM
|
|
Zenith Presentation at AACR Meeting April 10-15
|
4
|
Zenith Epigenetics
|
Apr 09, 2021 02:43PM
|
|
Zacks SCR Resverlogix Report 11/5/18; Apabetalone: The Last Mile
|
4
|
Resverlogix Corp.
|
Nov 06, 2018 04:51PM
|
|
Re: No ESC 2019 Late Breaker
|
4
|
Resverlogix Corp.
|
Jul 02, 2019 09:42AM
|
|
Re: AACR 2018
|
4
|
Zenith Epigenetics
|
Feb 21, 2018 05:52PM
|
|
AAIC presentation in July
|
4
|
Resverlogix Corp.
|
Jun 19, 2018 12:06PM
|
|
Re: HDL from an Alzheimer's disease perspective
|
4
|
Resverlogix Corp.
|
Jun 27, 2019 11:49AM
|
|
Melanotransferrin receptor vs. Transferrin Recepor
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jul 02, 2018 03:25PM
|
|
Re: Withholding
|
4
|
Resverlogix Corp.
|
Jul 05, 2017 02:57PM
|
|
Re: BETonMACE Enrollment
|
4
|
Resverlogix Corp.
|
Aug 18, 2019 08:24PM
|
|
Re: Statistical Considerations
|
4
|
Resverlogix Corp.
|
Mar 09, 2018 09:57AM
|
|
Re: Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone
|
4
|
Resverlogix Corp.
|
Aug 07, 2018 07:21AM
|
|
RVX Webcast 9/10 10:25 AM (EST) at Rodman and Renshaw
|
4
|
Resverlogix Corp.
|
Sep 04, 2015 03:05PM
|
